DISIPAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Disipal, and what generic alternatives are available?
Disipal is a drug marketed by 3M and is included in one NDA.
The generic ingredient in DISIPAL is orphenadrine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the orphenadrine hydrochloride profile page.
Summary for DISIPAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 3,425 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DISIPAL at DailyMed |
US Patents and Regulatory Information for DISIPAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3m | DISIPAL | orphenadrine hydrochloride | TABLET;ORAL | 010653-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |